loading

PSORIASIS

Psoriasis (commonly known as “Sedef Hastalığı”) is a chronic inflammatory skin disease driven by a combination of genetic predisposition, immune system dysfunction, and environmental triggers. It manifests as raised, red patches covered with silvery-white scales (plaques) and follows a lifelong course marked by flare-ups and remission. Beyond skin involvement, psoriasis can affect nails and joints, with up to 30% of patients developing psoriatic arthritis. Common sites include the knees, elbows, scalp, lower back, hands, feet, and genital area.


Key Symptoms:

  • Erythematous, scaly plaques with well-defined edges.

  • Itching, burning, or soreness in affected areas.

  • Nail changes: Pitting, thickening, or separation from the nail bed.

  • Joint pain, stiffness, or swelling (indicative of psoriatic arthritis).


Common Triggers:

  • Immune factors: Overactivation of T-cells and inflammatory cytokines (e.g., TNF-α, IL-17).

  • Stress: Emotional or physical stress exacerbates flares.

  • Infections: Streptococcal infections (e.g., strep throat).

  • Medications: Beta-blockers, lithium, antimalarials.

  • Skin trauma: Koebner phenomenon (new lesions at injury sites).

  • Lifestyle factors: Smoking, obesity, alcohol consumption.

  • Environmental factors: Cold, dry weather.


Treatment Strategies:

Treatment is tailored to disease severity, location, and patient-specific factors (e.g., age, comorbidities):

  1. Topical Therapies:

    • Corticosteroids: Reduce inflammation and scaling.

    • Vitamin D analogs (e.g., calcipotriene): Slow skin cell growth.

    • Calcineurin inhibitors (e.g., tacrolimus): For sensitive areas (face, genitals).

    • Keratolytics (e.g., salicylic acid): Remove excess scales.

  2. Phototherapy:

    • Narrowband UVB: Slows cell turnover and reduces inflammation.

    • Excimer laser: Targets localized plaques.

  3. Systemic Therapies:

    • Immunosuppressants: Methotrexate, cyclosporine (for moderate-severe cases).

    • Biologic Therapies:

      • TNF-α inhibitors (e.g., adalimumab, infliximab).

      • IL-17/IL-23 inhibitors (e.g., secukinumab, ustekinumab).

    • JAK Inhibitors (e.g., tofacitinib): Block inflammatory signaling.

  4. Lifestyle Modifications:

    • Weight management, smoking cessation, and stress reduction.

    • Moisturizers and gentle skincare to protect the skin barrier.


Why Professional Care Matters:

  • Psoriasis is linked to comorbidities (e.g., cardiovascular disease, diabetes).

  • A dermatologist can:

    • Distinguish psoriasis from mimics (e.g., eczema, fungal infections).

    • Screen for psoriatic arthritis and systemic involvement.

    • Optimize treatment to balance efficacy and safety, especially with biologics.

    • Provide holistic care addressing physical and emotional impacts.